Claim(permalink)
Researchers at Cleveland Clinic began a phase I study in October 2021 to test the safety of a vaccine aimed at preventing the most aggressive form of breast cancer.
Factors
veracity
Political Leaning
Sentiment
Date published
2021-10-29
Entities
MarsAmerican Cancer SocietyBiotechnologyCleveland ClinicImmunologyPeer reviewGene therapyClinical trialLife expectancyBreast cancerProteinBreastfeedingImmune systemCenters for Disease Control and PreventionCancerVaccineBRCA2Budd CompanyEndometrial cancerTriple-negative breast cancerVincent van GoghEstrogen receptorBRCA1Hormone therapyNeu!AdjuvantScientific journalCancer immunotherapyInvestigational New Drug
